oncolytic adenovirus therapy translocating YB-1 (Xvir Therapeutics)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug Nameoncolytic adenovirus therapy translocating YB-1 (Xvir Therapeutics)
Drug Alias NameXVir-N-31Xvir-03Xvir-05
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionY-Box Binding Protein 1 modulatorsImmunostimulants
TargetsY-Box Binding Protein 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesXvir Therapeutics GmbH
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesXvir Therapeutics GmbH
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A